Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study

被引:45
作者
Grundvold, Irene [1 ]
Bodegard, Johan [2 ]
Nilsson, Peter M. [3 ]
Svennblad, Bodil [4 ]
Johansson, Gunnar [5 ]
Ostgren, Carl Johan [6 ]
Sundstrom, Johan [4 ,7 ]
机构
[1] Oslo Univ Hosp, Dept Cardiol, N-0424 Oslo, Norway
[2] AstraZeneca Nord, Sodertalje, Sweden
[3] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden
[4] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden
[5] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden
[6] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden
[7] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
来源
Cardiovascular Diabetology | 2015年 / 14卷
关键词
Epidemiology; Atrial fibrillation; Type; 2; diabetes; Weight control; PRIMARY-CARE PATIENTS; CARDIOVASCULAR EVENTS; MASS INDEX; EUROPEAN-SOCIETY; COHORT; HYPERTENSION; ASSOCIATION; PREVALENCE; PREVENTION; MELLITUS;
D O I
10.1186/s12933-014-0170-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Obesity, type 2 diabetes and atrial fibrillation (AF) are closely associated, but the underlying mechanisms are not fully understood. We aimed to explore associations between body mass index (BMI) or weight change with risk of AF in patients with type 2 diabetes. Methods: A total of 7,169 participations with newly diagnosed type 2 diabetes were stratified according to baseline BMI, and after a second BMI measurement within 18 months, further grouped according to relative weight change as "weight gain" (> 1 BMI unit), " stable weight" (+/- 1 BMI unit) and " weight loss" (< 1 BMI unit). The mean follow-up period was 4.6 years, and the risk of AF was estimated using adjusted Cox regression models. Results: Average age at diabetes diagnosis was 60 years and the patients were slightly obese (mean BMI 30.2 kg/m(2)). During follow-up, 287 patients developed incident AF, and those with overweight or obesity at baseline had 1.9 fold and 2.9-fold higher risk of AF, respectively, than those with normal BMI. The 14% of the patients with subsequent weight gain had 1.5-fold risk of AF compared with those with stable weight or weight loss. Conclusions: In patients with newly diagnosed type 2 diabetes, baseline overweight and obesity, as well as modest weight increase during the first 18 months after diagnosis, were associated with a substantially increased risk of incident AF. Patients with type 2 diabetes may benefit from efforts to prevent weight gain in order to reduce the risk of incident AF.
引用
收藏
页数:7
相关论文
共 29 条
[1]  
[Anonymous], 2000, Obesity: preventing and managing the global epidemic: report of a WHO consultation, P253
[2]   Obesity, Diabetes and Atrial Fibrillation; Epidemiology, Mechanisms and Interventions [J].
Asghar, O. ;
Alam, U. ;
Hayat, S. A. ;
Aghamohammadzadeh, R. ;
Heagerty, A. M. ;
Malik, R. A. .
CURRENT CARDIOLOGY REVIEWS, 2012, 8 (04) :253-264
[3]   Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature [J].
Balena, R. ;
Hensley, I. E. ;
Miller, S. ;
Barnett, A. H. .
DIABETES OBESITY & METABOLISM, 2013, 15 (06) :485-502
[4]   Prevention of Atrial Fibrillation Report From a National Heart, Lung, and Blood Institute Workshop [J].
Benjamin, Emelia J. ;
Chen, Peng-Sheng ;
Bild, Diane E. ;
Mascette, Alice M. ;
Albert, Christine M. ;
Alonso, Alvaro ;
Calkins, Hugh ;
Connolly, Stuart J. ;
Curtis, Anne B. ;
Darbar, Dawood ;
Ellinor, Patrick T. ;
Go, Alan S. ;
Goldschlager, Nora F. ;
Heckbert, Susan R. ;
Jalife, Jose ;
Kerr, Charles R. ;
Levy, Daniel ;
Lloyd-Jones, Donald M. ;
Massie, Barry M. ;
Nattel, Stanley ;
Olgin, Jeffrey E. ;
Packer, Douglas L. ;
Po, Sunny S. ;
Tsang, Teresa S. M. ;
Van Wagoner, David R. ;
Waldo, Albert L. ;
Wyse, D. George .
CIRCULATION, 2009, 119 (04) :606-618
[5]   Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: A cohort study of 8486 primary-care patients [J].
Bodegard, J. ;
Sundstrom, J. ;
Svennblad, B. ;
Ostgren, C. J. ;
Nilsson, P. M. ;
Johansson, G. .
DIABETES & METABOLISM, 2013, 39 (04) :306-313
[6]  
Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]
[7]   Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies [J].
Chang, Shang-Hung ;
Wu, Lung-Sheng ;
Chiou, Meng-Jiun ;
Liu, Jia-Rou ;
Yu, Kuang-Hui ;
Kuo, Chang-Fu ;
Wen, Ming-Shien ;
Chen, Wei-Jan ;
Yeh, Yung-Hsin ;
See, Lai-Chu .
CARDIOVASCULAR DIABETOLOGY, 2014, 13
[8]   National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants [J].
Danaei, Goodarz ;
Finucane, Mariel M. ;
Lu, Yuan ;
Singh, Gitanjali M. ;
Cowan, Melanie J. ;
Paciorek, Christopher J. ;
Lin, John K. ;
Farzadfar, Farshad ;
Khang, Young-Ho ;
Stevens, Gretchen A. ;
Rao, Mayuree ;
Ali, Mohammed K. ;
Riley, Leanne M. ;
Robinson, Carolyn A. ;
Ezzati, Majid .
LANCET, 2011, 378 (9785) :31-40
[9]   Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study [J].
Du, Xin ;
Ninomiya, Toshiharu ;
de Galan, Bastiaan ;
Abadir, Edward ;
Chalmers, John ;
Pillai, Avinesh ;
Woodward, Mark ;
Cooper, Mark ;
Harrap, Stephen ;
Hamet, Pavel ;
Poulter, Neil ;
Lip, Gregory Y. H. ;
Patel, Anushka .
EUROPEAN HEART JOURNAL, 2009, 30 (09) :1128-1135
[10]   Risk of new-onset atrial fibrillation in relation to body mass index [J].
Dublin, Sascha ;
French, Benjamin ;
Glazer, Nicole L. ;
Wiggins, Kerri L. ;
Lumley, Thomas ;
Psaty, Bruce M. ;
Smith, Nicholas L. ;
Heckbert, Susan R. .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (21) :2322-2328